Joined Cases C-6/21 P and C-16/21 P: Judgment of the Court (Third Chamber) of 22 June 2023 — Federal Republic of Germany (C-6/21 P), Republic of Estonia (C-16/21 P) v Pharma Mar SA, European Commission (Appeal — Public health — Medicinal products for human use — Regulation (EC) No 726/2004 — Refusal of a marketing authorisation for the medicinal product for human use — Aplidin — plitidepsin — European Medicines Agency (EMA) — Impartiality of experts from a scientific advisory group (SAG) — Policy of the European Medicines Agency on the handling of competing interests of scientific committees’ members and experts — Concept of ‘pharmaceutical company’ — Scope of the exclusion for ‘research organisations’ — Concept of ‘rival products’)